Tatalick L M, Perryman L E
Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman 99164-7040, USA.
Vet Immunol Immunopathol. 1995 Jul;47(1-2):43-55. doi: 10.1016/0165-2427(94)05391-5.
We tested the hypothesis that adoptive transfer of immune spleen cell subsets from Cryptosporidium parvum antigen immunized, immunocompetent BALB/c mice would prevent initial infection or terminate persistent infection in severe combined immunodeficient (scid) mice. Cell donor mice were immunized with either solubilized C. parvum oocysts and sporozoites (positive control) or a surface antigen-1 (SA-1) enriched C. parvum antigen fraction. Both groups of BALB/c cell donor mice immunized with C. parvum antigens had increased antibody titers and lymphoproliferative responses when compared with negative control mice injected with phosphate buffered saline and adjuvant. Intravenous adoptive transfer of 5 x 10(6) cells of each cell subset (spleen cells, CD4 T and B lymphocytes, CD4 T lymphocytes or B lymphocytes) derived from immunized adult BALB/c donor mice did not protect scid mice against initial infection of the gastrointestinal epithelium with C. parvum, despite flow cytometric evidence of CD4 T lymphocyte engraftment in the spleen and detectable levels of C. parvum-specific serum antibody. In contrast, intravenous injection of either naive or immune CD4 T and B lymphocytes combined, or CD4 T lymphocytes alone, terminated persistent C. parvum infection in scid mice. Intestinal infectivity scores were significantly reduced by 9 days post-engraftment in all groups and continued to decline throughout the remainder of the experiment. Flow cytometric analysis demonstrated significantly increased CD4 T lymphocytes in the spleens of recipient scid mice when compared with infected scid mice receiving no cells. Cryptosporidium parvum-specific antibody was detected on day 12 post engraftment in mice receiving SA-1 immune CD4 T and B lymphocytes but was not detectable in mice receiving naive cell subsets.
从小鼠隐孢子虫抗原免疫的免疫活性BALB/c小鼠中过继转移免疫脾细胞亚群,可预防严重联合免疫缺陷(scid)小鼠的初始感染或终止持续性感染。细胞供体小鼠用溶解的微小隐孢子虫卵囊和子孢子(阳性对照)或富含表面抗原-1(SA-1)的微小隐孢子虫抗原组分进行免疫。与注射磷酸盐缓冲盐水和佐剂的阴性对照小鼠相比,两组用微小隐孢子虫抗原免疫的BALB/c细胞供体小鼠的抗体滴度和淋巴细胞增殖反应均增加。尽管流式细胞术证明免疫的成年BALB/c供体小鼠来源的每个细胞亚群(脾细胞、CD4 T和B淋巴细胞、CD4 T淋巴细胞或B淋巴细胞)的5×10(6)个细胞经静脉过继转移,scid小鼠仍不能抵御微小隐孢子虫对胃肠道上皮的初始感染,尽管脾中有CD4 T淋巴细胞植入的流式细胞术证据以及可检测水平的微小隐孢子虫特异性血清抗体。相比之下,静脉注射未免疫或免疫的CD4 T和B淋巴细胞组合,或单独注射CD4 T淋巴细胞,可终止scid小鼠的持续性微小隐孢子虫感染。移植后9天,所有组的肠道感染性评分均显著降低,并在实验的其余时间持续下降。流式细胞术分析表明,与未接受细胞的感染scid小鼠相比,受体scid小鼠脾脏中的CD4 T淋巴细胞显著增加。在接受SA-1免疫的CD4 T和B淋巴细胞的小鼠移植后第12天检测到微小隐孢子虫特异性抗体,但在接受未免疫细胞亚群的小鼠中未检测到。